Abstract
The impact of COVID-19 varied significantly by deprivation, ethnicity, and policy measures. We analysed individual-level data on 12,310,485 first SARS-CoV-2 Pillar-2-PCR-confirmed infections, 439,083 hospitalisations, 107,823 deaths, and vaccination records in England from May 2020 to February 2022. Poisson regression models adjusted for demographic and temporal factors showed higher incidence rate ratios (IRRs) for severe outcomes in the most deprived areas compared to the least. We note higher IRRs for severe outcomes for all non-White relative to White ethnicities. The magnitude of IRRs for both deprivation and ethnicities declined from the wild-type to the omicron periods for severe outcomes. For infections, we observed IRRs above one for non-White ethnicities during the wild-type and alpha periods. Vaccination significantly reduced risks across all groups. For severe outcomes, pre-existing health inequalities led to large and persistent disparities. For infections, measures must be structured with ethnicity and deprivation in mind early in a pandemic.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
All authors acknowledge funding from the Medical Research Council (MRC) Centre for Global Infectious Disease Analysis (MR/X020258/1) funded by the UK MRC and carried out in the frame of the Global Health EDCTP3 Joint Undertaking supported by the EU; the NIHR for support for the Health Research Protection Unit in Modelling and Health Economics, a partnership between the UK Health Security Agency (UKHSA), Imperial College London, and London School of Hygiene & Tropical Medicine (grant code NIHR200908); a philanthropic donation from Community Jameel supporting the work of the Jameel Institute S.B. acknowledges support from the Novo Nordisk Foundation via The Novo Nordisk Young Investigator Award (NNF20OC0059309). SB acknowledges the Danish National Research Foundation (DNRF160) through the chair grant. S.B. acknowledges support from Schmidt Sciences via the Schmidt Polymath Award (G-22-63345), which also supports C.M.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics committee permission was sought for the study via Imperial College Londons standard ethical review processes, and the study was approved by the Colleges Research Governance and Integrity Team (ICREC reference: 21IC6945).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
We have updated the manuscript following reviewer comments, in particular we have added additional analysis for vaccine effectiveness by deprivation.
Data Availability
While all data used in this analysis were anonymised, the individual-level nature of the data used risks individuals being identified or being able to self-identify if it is released publicly. Requests for access to the underlying source data should be directed to UKHSA.
